{
    "code": "02025362",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025362",
    "time": "2020-12-25 05:50:56",
    "許可證字號": "衛署藥輸字第025362號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/02\/21",
    "發證日期": "100\/02\/21",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202536202",
    "中文品名": "鹽酸梯可匹定",
    "英文品名": "Ticlopidine Hydrochloride",
    "適應症": "抗凝血劑",
    "劑型": "040（粉）",
    "包裝": "０．５公斤以上",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "01製劑原料",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "",
    "申請商名稱": "0941901100  恒亞貿易有限公司",
    "申請商地址": "台北市士林區延平北路六段485號4樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIN0630100  AARTI DRUGS LIMITED",
            "製造廠廠址": "PLOT NO. W-71(B), 72(B), MIDC TARAPUR, TAL. PALGHAR, DIST. THANE - 401506, MAHARASHTRA, INDIA",
            "製造廠公司地址": "",
            "製造廠國別": "INDIA",
            "製程": ""
        }
    ],
    "CCC號列": "29349990901 其他雜環化合物Other heterocyclic compounds",
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "020253620002___20110407.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025362&Seq=002&Type=8"
        }
    ]
}